Health
Study: Hydroxychloroquine plus azithromycin linked to significant cardiovascular risks – News-Medical.Net
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM.
Reviewed by Emily Henderson, B.Sc.Aug 25 2020
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM. This network study, led by the Observational Health Data Sciences and Informatics community, was recently published in Lancet Rheumatology.
OHDSI has established an international network of researchers and observational health databases with a…
-
Business13 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General23 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News13 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News13 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots